- What other names is Andrographis known by?
- What is Andrographis?
- How does Andrographis work?
- Are there safety concerns?
- Are there any interactions with medications?
- Dosing considerations for Andrographis.
Andrographis Paniculata, Andrographolide, Bhunimba, Bidara, Carmantina, Carmantine, Chiretta, Chirette Verte, Chirreta, Chuan Xin Lian, Chuanxinlian, Chuan Xin Lin, Creat, Échinacée d'Inde, Fa-Tha-Lai-Jone, Fa-Tha-Lai-Jone, Gubak, Herba Andrographitis, Indian Echinacea, Justicia paniculata, Justicie, Kalamegha, Kalmegh, Kalmegha, Kariyat, King of Bitters, Kirta, Mahalita, Nabin Chanvandi, Poogiphalam, Roi des Amers, Sadilata, Sambilata, Shivaphala, Supari, Takila, Vizra Ufar, Yavatikta.
Andrographis is a plant that is native to South Asian countries such as India and Sri Lanka. The leaf and underground stem are used to make medicine.
Andrographis is frequently used for preventing and treating the common cold and flu (influenza). Some people claim andrographis stopped the 1919 flu epidemic in India, although this has not been proven.
Andrographis is also used for a wide assortment of other conditions. It is used for digestive complaints including diarrhea, constipation, intestinal gas, colic, and stomach pain; for liver conditions including an enlarged liver, jaundice, and liver damage due to medications; for infections including leprosy, pneumonia, tuberculosis, gonorrhea, syphilis, malaria, cholera, leptospirosis, rabies, sinusitis, and HIV/AIDS; and for skin conditions including wounds, ulcers and itchiness.
Some people use andrographis for sore throat, coughs, swollen tonsils, bronchitis, and allergies. It is also used for “hardening of the arteries” (atherosclerosis), and prevention of heart disease and diabetes.
Some Internet vendors offer andrographis products that contain extra amounts of an active ingredient called andrographolide. Some of these products are almost 30% andrographolide. However, be careful; the safety and effectiveness of andrographis preparations with high andrographolide content are unknown.
Possibly Effective for...
- Common cold. Some research shows that taking a specific andrographis extract in combination with Siberian ginseng (Kan Jang, Swedish Herbal Institute) by mouth improves symptoms of the common cold when started within 72 hours of feeling sick. Some symptoms can improve after 2 days of treatment, but it usually takes 4-5 days of treatment before most symptoms go away. Some research suggests this combination of andrographis and Siberian ginseng relieves cold symptoms in children better than echinacea. Also, early research suggests that taking a specific andrographis extract (KalmCold) might help treat colds, while other research suggests that taking a specific andrographis product (Kan Jang, Swedish Herbal Institute) might help prevent colds.
- Reducing the fever and sore throat due to tonsillitis. Some research shows that high dose andrographis (6 grams daily) works about as well as acetaminophen (Tylenol) after 3 to 7 days of treatment.
- Inflammatory bowel disease (ulcerative colitis). Early research suggests that taking andrographis extract daily for 8 weeks reduces symptoms of inflammatory bowel disease about as well as the drug mesalamine.
Insufficient Evidence to Rate Effectiveness for...
- Familial Mediterranean fever. Developing research suggests that a combination of andrographis, Siberian ginseng, schisandra, and licorice (ImmunoGuard, Inspired Nutritionals) reduces the length, number, and severity of attacks of familial Mediterranean fever in children.
- Treating flu (Influenza). There is some evidence that patients with flu who take a specific Andrographis extract in combination with Siberian ginseng (Kan Jang, Swedish Herbal Institute) feel better more quickly than patients taking amantadine, a drug approved by the federal Food and Drug Administration (FDA) to prevent Asian flu and treat Influenza A. Patients who take this herbal combination also seem to have fewer complications such as sinus pain, as well as breathing problems and coughing (bronchitis), after the flu.
- Rheumatoid arthritis. Early research suggests that taking andrographis for 14 weeks reduces symptoms of rheumatoid arthritis when compared with pretreatment, but not when compared to another group of people taking just a sugar pill.
- Sinus infections.
- Heart disease.
- Liver problems.
- Skin diseases.
- Other conditions.
Andrographis is LIKELY SAFE when taken by mouth appropriately, short-term. It also appears to be safe when taken as a specific combination product containing andrographis extract and Siberian ginseng (Kan Jang, Swedish Herbal Institute) for up to 3 months.
Special Precautions & Warnings:Infants and children: Andrographis is POSSIBLY SAFE in children when taken by mouth, short-term. Andrographis has been used in combination with other herbs for up to one month.
Pregnancy and breast-feeding: Andrographis is POSSIBLY UNSAFE when taken by mouth during pregnancy. There is a concern that it might cause miscarriages. Not enough is known about the safety of andrographis during breast-feeding. Stay on the safe side, and avoid using andrographis if you are pregnant or breast-feeding.
Fertility problems: Animal research suggests that andrographis might interfere with reproduction, but this hasn't been shown in people. Nevertheless, if you are having trouble fathering a child or getting pregnant, it's best not to use andrographis.
“Auto-immune diseases” such as multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), or other conditions: Andrographis might cause the immune system to become more active, and this could increase the symptoms of auto-immune diseases. If you have one of these conditions, it's best to avoid using andrographis.
Bleeding conditions: Andrographis might slow blood clotting. This might increase the risk of bleeding or bruising in people with bleeding disorders.
Low blood pressure: Research suggests that andrographis might lower blood pressure. This has not been seen in humans. In theory, however, andrographis might lower pressure too much if taken by people who already have low blood pressure.
Medications for high blood pressure (Antihypertensive drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Andrographis seems to decrease blood pressure. Taking andrographis along with medications for high blood pressure might cause your blood pressure to go too low.
Some medications for high blood pressure include captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), Amlodipine (Norvasc), hydrochlorothiazide (HydroDiuril), furosemide (Lasix), and many others.
Medications that decrease the immune system (Immunosuppressants)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Andrographis increases the immune system. By increasing the immune system, andrographis might decrease the effectiveness of medications that decrease the immune system.
Some medications that decrease the immune system include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), and others.
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Andrographis might slow blood clotting. Taking andrographis along with medications that also slow clotting might increase the chances of bruising and bleeding.
Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.
The following doses have been studied in scientific research:
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors
Akbar, S. Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern.Med Rev. 2011;16(1):66-77. View abstract.
Akbarsha, M. A. and Murugaian, P. Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: effect on the testis and the cauda epididymidal spermatozoa. Phytother.Res. 2000;14(6):432-435. View abstract.
Basak, A., Cooper, S., Roberge, A. G., Banik, U. K., Chretien, M., and Seidah, N. G. Inhibition of proprotein convertases-1, -7 and furin by diterpines of Andrographis paniculata and their succinoyl esters. Biochem.J. 2-15-1999;338 ( Pt 1):107-113. View abstract.
Batkhuu, J., Hattori, K., Takano, F., Fushiya, S., Oshiman, K., and Fujimiya, Y. Suppression of NO production in activated macrophages in vitro and ex vivo by neoandrographolide isolated from Andrographis paniculata. Biol.Pharm.Bull. 2002;25(9):1169-1174. View abstract.
Borhanuddin, M., Shamsuzzoha, M., and Hussain, A. H. Hypoglycaemic effects of Andrographis paniculata Nees on non-diabetic rabbits. Bangladesh Med.Res.Counc.Bull. 1994;20(1):24-26. View abstract.
Burgos, R. A., Hancke, J. L., Bertoglio, J. C., Aguirre, V., Arriagada, S., Calvo, M., and Caceres, D. D. Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial. Clin Rheumatol. 2009;28(8):931-946. View abstract.
Burns, J. J., Zhao, L., Taylor, E. W., and Spelman, K. The influence of traditional herbal formulas on cytokine activity. Toxicology 11-28-2010;278(1):140-159. View abstract.
Caceres, D. D., Hancke, J. L., Burgos, R. A., and Wikman, G. K. Prevention of common colds with Andrographis paniculata dried extract: A pilot double blind trial. Phytomedicine 1997;4:101-104.
Chandrasekaran, C. V., Murali, B., Deepak, M., and Agarwal, A. In vitro comparative evaluation of non-leaves and leaves extracts of Andrographis paniculata on modulation of inflammatory mediators. Antiinflamm.Antiallergy.Agents Med Chem 2012;11(2):191-197. View abstract.
Chen, J. H., Hsiao, G., Lee, A. R., Wu, C. C., and Yen, M. H. Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. Biochem Pharmacol 4-1-2004;67(7):1337-1345. View abstract.
Chen, Q., Liu, Y., Liu, Y. M., Liu, G. Y., Zhang, M. Q., Jia, J. Y., Lu, C., and Yu, C. Pharmacokinetics and tolerance of dehydroandrographolide succinate injection after intravenous administration in healthy Chinese volunteers. Acta Pharmacol Sin. 2012;33(10):1332-1336. View abstract.
Cheung, H. Y., Cheung, S. H., Li, J., Cheung, C. S., Lai, W. P., Fong, W. F., and Leung, F. M. Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med 2005;71(12):1106-1111. View abstract.
Chiou, W. F., Chen, C. F., and Lin, J. J. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br.J.Pharmacol. 2000;129(8):1553-1560. View abstract.
Chiou, W. F., Lin, J. J., and Chen, C. F. Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide. Br.J.Pharmacol. 1998;125(2):327-334. View abstract.
Choudhury, B. R. and Poddar, M. K. Andrographolide and kalmegh (Andrographis paniculata) extract: effect on intestinal brush-border membrane-bound hydrolases. Methods Find.Exp Clin Pharmacol. 1985;7(12):617-621. View abstract.
Cui, L., Chan, W., Qiu, F., Cai, Z., and Yao, X. Identification of four urea adducts of andrographolide in humans. Drug Metab Lett. 2008;2(4):261-268. View abstract.
Ghosh, N., Ghosh, R., Mandal, V., and Mandal, S. C. Recent advances in herbal medicine for treatment of liver diseases. Pharm Biol. 2011;49(9):970-988. View abstract.
Guo, Z. L., Zhao, H. Y., and Zheng, X. H. An experimental study of the mechanism of andrographis paniculata nees (APN) in alleviating the Ca(2+)-overloading in the process of myocardial ischemic reperfusion. J.Tongji Med.Univ 1995;15(4):205-208. View abstract.
Hancke, J., Burgos, R., Caceres, D., and Wikman, G. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds. Phytother Res. 1995;1995(9):-559.
Hidalgo, M. A., Romero, A., Figueroa, J., Cortes, P., Concha, I. I., Hancke, J. L., and Burgos, R. A. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. Br.J.Pharmacol. 2005;144(5):680-686. View abstract.
Iruretagoyena, M. I., Tobar, J. A., Gonzalez, P. A., Sepulveda, S. E., Figueroa, C. A., Burgos, R. A., Hancke, J. L., and Kalergis, A. M. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J.Pharmacol.Exp Ther. 2005;312(1):366-372. View abstract.
Jada, S. R., Hamzah, A. S., Lajis, N. H., Saad, M. S., Stevens, M. F., and Stanslas, J. Semisynthesis and cytotoxic activities of andrographolide analogues. J Enzyme Inhib.Med Chem 2006;21(2):145-155. View abstract.
Kibirev, V. K. and Osadchuk, T. V. [Structure and properties of proprotein convertase inhibitors]. Ukr.Biokhim.Zh. 2012;84(2):5-29. View abstract.
Kligler, B., Ulbricht, C., Basch, E., Kirkwood, C. D., Abrams, T. R., Miranda, M., Singh Khalsa, K. P., Giles, M., Boon, H., and Woods, J. Andrographis paniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration. Explore.(NY) 2006;2(1):25-29. View abstract.
Kuttan, G., Pratheeshkumar, P., Manu, K. A., and Kuttan, R. Inhibition of tumor progression by naturally occurring terpenoids. Pharm Biol 2011;49(10):995-1007. View abstract.
Li, W., Xu, X., Zhang, H., Ma, C., Fong, H., van Breemen, R., and Fitzloff, J. Secondary metabolites from Andrographis paniculata. Chem Pharm Bull.(Tokyo) 2007;55(3):455-458. View abstract.
Lim, J. C., Chan, T. K., Ng, D. S., Sagineedu, S. R., Stanslas, J., and Wong, W. S. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin Exp.Pharmacol Physiol 2012;39(3):300-310. View abstract.
Madav, S., Tripathi, H. C., and Tanden Mishra, S. K. Analgesic, antipyretic and antiulcerogenic effects of Andrographolide. Indian J Pharm Sci 1995;57:121-125.
Melchior, J., Palm, S., and Wikman, G. Controlled clinical study of standardized Andrographis paniculata extract in common cold - a pilot trial. Phytomedicine. 1997;3(4):315-318. View abstract.
Negi, A. S., Kumar, J. K., Luqman, S., Shanker, K., Gupta, M. M., and Khanuja, S. P. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. Med.Res Rev. 2008;28(5):746-772. View abstract.
Panossian, A., Davtyan, T., Gukassyan, N., Gukasova, G., Mamikonyan, G., Gabrielian, E., and Wikman, G. Effect of andrographolide and Kan Jang--fixed combination of extract SHA-10 and extract SHE-3--on proliferation of human lymphocytes, production of cytokines and immune activation markers in the whole blood cells culture. Phytomedicine. 2002;9(7):598-605. View abstract.
Panossian, A., Hovhannisyan, A., Mamikonyan, G., Abrahamian, H., Hambardzumyan, E., Gabrielian, E., Goukasova, G., Wikman, G., and Wagner, H. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine. 2000;7(5):351-364. View abstract.
Rajagopal, S., Kumar, R. A., Deevi, D. S., Satyanarayana, C., and Rajagopalan, R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J.Exp.Ther.Oncol. 2003;3(3):147-158. View abstract.
Sandborn, W. J., Targan, S. R., Byers, V. S., Rutty, D. A., Mu, H., Zhang, X., and Tang, T. Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol. 2013;108(1):90-98. View abstract.
Saxena, R. C., Singh, R., Kumar, P., Yadav, S. C., Negi, M. P., Saxena, V. S., Joshua, A. J., Vijayabalaji, V., Goudar, K. S., Venkateshwarlu, K., and Amit, A. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. 2010;17(3-4):178-185. View abstract.
Shen, Y. C., Chen, C. F., and Chiou, W. F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br.J.Pharmacol. 2002;135(2):399-406. View abstract.
Singh, P., Singh, I. N., Mondal, S. C., Singh, L., and Garg, V. K. Platelet-activating factor (PAF)-antagonists of natural origin. Fitoterapia 2013;84:180-201. View abstract.
Smith, P. L., Maloney, K. N., Pothen, R. G., Clardy, J., and Clapham, D. E. Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J Biol Chem 10-6-2006;281(40):29897-29904. View abstract.
Tang, T., Targan, S. R., Li, Z. S., Xu, C., Byers, V. S., and Sandborn, W. J. Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment.Pharmacol Ther 2011;33(2):194-202. View abstract.
Wibudi, A., Kiranadi, B., Manalu, W., winarto, A., and Suyono, S. The traditional plant, Andrographis paniculata (Sambiloto), exhibits insulin-releasing actions in vitro. Acta Med Indones. 2008;40(2):63-68. View abstract.
Yu, B. C., Hung, C. R., Chen, W. C., and Cheng, J. T. Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med. 2003;69(12):1075-1079. View abstract.
Zhang, C. Y. and Tan, B. K. Hypotensive activity of aqueous extract of Andrographis paniculata in rats. Clin Exp Pharmacol.Physiol 1996;23(8):675-678. View abstract.
Zhou, J., Zhang, S., Ong, C. N., and Shen, H. M. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol 7-14-2006;72(2):132-144. View abstract.
Akbarsha MA, Manivannan B, Hamid KS, Vijayan B. Antifertility effect of Andrographis paniculata (Nees) in male albino rat. Indian J Exp Biol 1990;28:421-6. View abstract.
Amaryan G, Astvatsatryan V, Gabrielyan E, et al. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever. Phytomedicine 2003;10:271-85. View abstract.
Amroyan E, Gabrielian E, Panossian A, et al. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 1999;6:27-31. View abstract.
Burgos RA, Caballero EE, Sanchez NS, et al. Testicular toxicity assessment of Andrographis paniculata dried extract in rats. J Ethnopharmacol 1997;58:219-24. View abstract.
Caceres DD, Hancke JL, Burgos RA, et al. Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized, double-blind, placebo study. Phytomedicine 1999;6:217-23.. View abstract.
Caceres DD, Hancke JL, Burgos RA, Wikman GK. Prevention of common colds with Andrographis Paniculata dried extract: a pilot, double-blind trial. Phytomedicine 1997;4:101-4.
Calabrese C, Berman SH, Babish JG, et al. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 2000;14:333-8. View abstract.
Chang RS, Ding L, Chen GQ, et al. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med 1991;197:59-66. View abstract.
Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med 2004;70:293-8. View abstract.
Dr. Duke's Phytochemical and Ethnobotanical Databases. Ethnobotanical uses: Andrographis paniculata. www.ars-grin.gov/cgi-bin/duke/ethnobot.pl?andrographis%20pnaiculata (Accessed 27 January 2000).
Gabrielian ES, Shukarian AK, Goukasova GI, et al. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine 2002;9:589-97.. View abstract.
Gozalbes R, Galvez J, Garcia-Domenech R, Derouin F. Molecular search of new active drugs against Toxoplasma gondii. SAR QSAR Environ Res 1999;10:47-60. View abstract.
Guo Z, Zhao H, Fu L. Protective effects of API0134 on myocardial ischemia and reperfusion injury. J Tongji Med Univ 1996;16:193-7. View abstract.
Guo ZL, Zhao HY, Zheng XH. The effect of andrographis paniculata nees (APN) in alleviating the myocardial ischemic reperfusion injury. J Tongji Med Univ 1994;14:49-51. View abstract.
Gupta PP, Tandon JS, Patnaik GK. Antiallergic activity of andrographolides isolated from Andrographis paniculata (Burm. F) Wall. Pharm Biol 1998;36:72-4.
Gupta S, Yadava JN, Tandon JS. Antisecretory (antidiarrheal) activity of Indian medicinal plants against Escherchia coli enterotoxin-induced secretion in rabbit and guinea pig ileal loop models. Int J Pharmacogn 1993;31:198-204.
Hancke J, Burgos R, Caceres D, Wikman G. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds. Phytotherapy Res 1995;9:559-62.
Indian Herbs. Andrographis paniculata. www.indianherbs.com (Accessed 23 June 2004).
Kapil A, Koul IB, Banerjee SK, Gupta BD. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol 1993;46:182-5. View abstract.
Kulichenko LL, Kireyeva LV, Malyshkina EN, Wikman G. A Randomized, Controlled Study of Kan Jang versus Amantadine in the Treatment of Influenza in Volgograd. J Herb Pharmacother 2003;3:77-92. View abstract.
Kumar RA, Sridevi K, Kumar NV, et al. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 2004;92:291-5. View abstract.
Kumar S, Gopal K. Screening of plant species for inhibition of bacterial population of raw water. J Environ Sci Health A Tox Hazard Subst Environ Eng 1999;34:975-87.
Leelarasamee A, Trakulsomboon S, Sittisomwong N. Undetectable anti-bacterial activity of Andrographis paniculata (Burma) wall. ex ness. J Med Assoc Thai 1990;73:299-304. View abstract.
Madav S, Tripathi HC, Tandan Mishra SK. Analgesic, antipyretic and antiulcerogenic effects of andrographolide. Indian J Pharm Sci 1995;57:121-5.
Madav S, Tripathi HC, Tandan SK, et al. Antiallergic activity of andrographolide. Indian J Pharm Sci 1998;60:176-8.
Matsuda T, Kuroyanagi M, Sugiyama S, et al. Cell differentiation-inducing diterpenes from Andrographis paniculata Nees. Chem Pharm Bull (Tokyo)1994;42:1216-25. View abstract.
Melchior J, Palm S, Wikman G. Controlled clinical study of standardized Andrographis paniculata in common cold- a pilot trial. Phytomedicine 1996;97;3:315-8.
Melchoir J, Spasov AA, Ostrovskij OV, et al. Double-blind, placebo-controlled pilot and phase III study of activity of standardized Andrographis paniculata Herba Nees extract fixed combination (Kan Jang) in the treatment of uncomplicated upper-respiratory tract infection. Phytomedicine 2000;7:341-50. View abstract.
Misra P, Pal NL, Guru PY, et al. Antimalarial activity of Andrographis paniculata (Kalmegh) against Plasmodium berghei NK 65 in Mastomys natalensis. Int J Pharmacogn 1992;30:263-74.
Najib NA, Rahman N, Furuta T, et al. Antimalarial activity of extracts of Malaysian medicinal plants. J Ethnopharmacol 1999;64:249-54. View abstract.
Panossian A, Kochikian A, Gabrielian E, et al. Effect of Andrographis paniculata extract on progesterone in blood plasma of pregnant rats. Phytomedicine 1999;6:157-61. View abstract.
Poolsup N, Suthisisang C, Prathanturarug S, et al. Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. J Clin Pharm Ther 2004;29:37-45. View abstract.
Puri A, Saxena R, Saxena RP, et al. Immunostimulant agents from Andrographis paniculata. J Nat Prod 1993;56:995-9. View abstract.
Raj RK. Screening of indigenous plants for anthelmintic action against human Ascaris lumbricoides:Part II. Ind J Physiol Pharmacol 1975;19;47-9. View abstract.
Rana AC, Avadhoot Y. Hepatoprotective effects of Andrographis paniculata against carbon tetrachloride-induced liver damage. Arch Pharm Res 1991;14:93-5. View abstract.
Shukla B, Visen PK, Patnaik GK, Dhawan BN. Choleretic effect of andrographolide in rats and guinea pigs. Planta Med 1992;58:146-9. View abstract.
Spasov AA, Ostrovskij OV, Chernikov MV, Wikman G. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children. Phytother Res 2004;18:47-53. View abstract.
Thamlikitkul V, Dechatiwongse T, Theerapong S, et al. Efficacy of Andrographis paniculata, Nees for pharyngotonsillitis in adults. J Med Assoc Thai 1991;74:437-42. View abstract.
Vedavathy S, Rao KN. Antipyretic activity of six indigenous medicinal plants of Tirumala Hills, Andhra Pradesh, India. J Ethnopharmacol 1991;33:193-6. View abstract.
Visen PK, Shukla B, Patnaik GK, Dhawan BN. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J Ethnopharmacol 1993;40:131-6. View abstract.
Wang DW, Zhao HY. Experimental studies on prevention of atherosclerotic arterial stenosis and restenosis after angioplasty with Andrographis Paniculata Nees and fish oil. J Tongji Med Univ 1993;13:193-8. View abstract.
Wang DW, Zhao HY. Prevention of atherosclerotic arterial stenosis and restenosis after angioplasty with Andrographis paniculata nees and fish oil. Experimental studies of effects and mechanisms. Chin Med J (Engl) 1994;107:464-70. View abstract.
Zhang C, Kuroyangi M, Tan BK. Cardiovascular activity of 14-deoxy-11,12-didehydroandrographolide in the anaesthetised rat and isolated right atria. Pharmacol Res 1998;38:413-7. View abstract.
Zhang CY, Tan BK. Mechanisms of cardiovascular activity of Andrographis paniculata in the anaesthetized rat. J Ethnopharmacol 1997;56:97-101. View abstract.
Zhao HY, Fang WY. Antithrombotic effects of Andrographis paniculata nees in preventing myocardial infarction. Chin Med J (Engl) 1991;104:770-5. View abstract.
Zoha MS, Hussain AH, Choudhury SA. Antifertility effect of andrographis paniculata in mice. Bangladesh Med Res Counc Bull 1989;15:34-7. View abstract.